A detailed history of Alpha Centric Advisors LLC transactions in Penumbra Inc stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 4,000 shares of PEN stock, worth $961,440. This represents 0.66% of its overall portfolio holdings.

Number of Shares
4,000
Holding current value
$961,440
% of portfolio
0.66%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$163.64 - $210.12 $654,560 - $840,480
4,000 New
4,000 $776,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.